Blauvelt A, Strober B, Langley R, Kavanagh S, Arendt C, Boehnlein M, Lebwohl M, Reich K. Safety of Certolizumab Pegol in Plaque Psoriasis: Pooled 96-Week Data from Three Phase 3, Multicenter, Randomized, Placebo-Controlled Studies (CIMPASI-1, CIMPASI-2 and CIMPACT). J of Skin [Internet]. 2019Nov.9 [cited 2024Jul.3];3:S39. Available from: https://jofskin.org/index.php/skin/article/view/766